Stock PRVA PRIVIA HEALTH GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Privia Health Group, Inc.

Equities

PRVA

US74276R1023

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
18.26 USD +1.50% Intraday chart for Privia Health Group, Inc. +1.00% -20.71%
Apr. 22 Citigroup Starts Privia Health Group With Buy Rating, $25 Price Target MT
Mar. 19 Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating MT

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 2,755 2,596 2,719 2,167 - -
Enterprise Value (EV) 1 2,467 2,248 2,330 1,708 1,618 1,514
P/E ratio -14.1 x -284 x 121 x 77.5 x 55.9 x 45.2 x
Yield - - - - - -
Capitalization / Revenue 2.85 x 1.91 x 1.64 x 1.32 x 1.16 x 1.01 x
EV / Revenue 2.55 x 1.66 x 1.41 x 1.04 x 0.86 x 0.7 x
EV / EBITDA 59.6 x 36.9 x 32.3 x 19.5 x 15.2 x 11.6 x
EV / FCF 45.3 x 47.7 x 28.9 x 22.6 x 17.6 x 12.9 x
FCF Yield 2.21% 2.1% 3.46% 4.43% 5.67% 7.78%
Price to Book 6.44 x 5.22 x 5.11 x 3.41 x 3.04 x 2.67 x
Nbr of stocks (in thousands) 106,499 114,299 118,064 118,656 - -
Reference price 2 25.87 22.71 23.03 18.26 18.26 18.26
Announcement Date 3/22/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 817.1 966.2 1,357 1,658 1,645 1,873 2,148
EBITDA 1 - 41.38 60.85 72.23 87.45 106.7 131
EBIT 1 - -217.4 -19.12 20.65 30.23 47.8 66.4
Operating Margin - -22.5% -1.41% 1.25% 1.84% 2.55% 3.09%
Earnings before Tax (EBT) 1 - -218.5 -18.58 29.02 39.06 55.93 71.55
Net income 1 - -188.2 -8.585 23.08 29.78 42.32 55.29
Net margin - -19.48% -0.63% 1.39% 1.81% 2.26% 2.57%
EPS 2 0.3300 -1.830 -0.0800 0.1900 0.2355 0.3266 0.4037
Free Cash Flow 1 - 54.51 47.09 80.67 75.66 91.7 117.8
FCF margin - 5.64% 3.47% 4.87% 4.6% 4.89% 5.48%
FCF Conversion (EBITDA) - 131.74% 77.39% 111.69% 86.51% 85.94% 89.86%
FCF Conversion (Net income) - - - 349.55% 254.05% 216.67% 212.96%
Dividend per Share 2 - - - - - - -
Announcement Date 3/17/21 3/22/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 251.5 275.3 313.8 335.5 342.9 364.4 386.3 413.4 417.3 440.8 394.1 407.4 413.4 430.3 455.7
EBITDA 1 13.87 7.528 14.8 15.53 15.65 14.26 16.86 19.31 18.77 17.28 19.75 21.99 23.22 22.42 23.59
EBIT 1 -12.81 -19.35 -11.55 -5.25 -4.574 2.249 6.714 6.979 5.536 1.42 5.63 7.768 8.942 8.2 10.22
Operating Margin -5.09% -7.03% -3.68% -1.56% -1.33% 0.62% 1.74% 1.69% 1.33% 0.32% 1.43% 1.91% 2.16% 1.91% 2.24%
Earnings before Tax (EBT) 1 -13.1 -19.53 -11.78 -5.913 -4.289 3.401 8.527 7.796 8.43 4.268 7.482 9.781 10.96 10.59 11.82
Net income 1 -9.115 -11.98 -17.51 -10.48 1.624 17.78 7.324 7.274 5.643 2.838 6.063 7.71 8.296 7.782 8.838
Net margin -3.62% -4.35% -5.58% -3.12% 0.47% 4.88% 1.9% 1.76% 1.35% 0.64% 1.54% 1.89% 2.01% 1.81% 1.94%
EPS 2 -0.0900 -0.1100 -0.1600 -0.1000 0.0100 0.1400 0.0600 0.0600 0.0500 0.0200 0.0475 0.0616 0.0676 0.0670 0.0695
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/8/21 3/22/22 5/12/22 8/11/22 11/10/22 2/28/23 5/4/23 8/3/23 11/3/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 288 348 390 458 549 653
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - 54.5 47.1 80.7 75.7 91.7 118
ROE (net income / shareholders' equity) - -65.6% -1.85% 4.35% 4.84% 5.34% 6.02%
ROA (Net income/ Total Assets) - -37.1% -1.16% 2.57% 2.82% 3.48% -
Assets 1 - 507.7 739.6 896.4 1,057 1,217 -
Book Value Per Share 2 - 4.020 4.350 4.500 5.350 6.000 6.850
Cash Flow per Share 2 - 0.5300 0.4300 0.6500 0.6000 0.6300 -
Capex 1 - 0.55 0.1 0.11 0.78 0.91 1.31
Capex / Sales - 0.06% 0.01% 0.01% 0.05% 0.05% 0.06%
Announcement Date 3/17/21 3/22/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Privia Health Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
18.26 USD
Average target price
27.28 USD
Spread / Average Target
+49.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
PRIVIA HEALTH GROUP, INC. Stock Privia Health Group, Inc.
-20.71% 2.17B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. PRVA Stock
  4. Financials Privia Health Group, Inc.